UP!

ABEO $2.01   View long term graphs

Abeona Therapeutics, Inc.
Type
Public
Industry Biomedicine
Founded Dallas, Texas 1989 (1989)
Headquarters United States
Website http://abeonatherapeutics.com/

Abeona Therapeutics, Inc. is a pharmaceutical development company. Its research focuses on developing treatments for rare diseases using gene therapy and human plasma-derived therapeutics. The company is trying to find ways to address Sanfilippo Syndrome, Fanconi anemia, and Juvenile Batten disease. It has stated it anticipates starting clinical trials on an adeno-associated virus-based gene therapy for Sanfilippo syndrome in 2015.

Abeona also is developing a salt diafiltration process for purifying proteins from blood plasma and a polymer hydrogel for delivering drugs.

The company was formerly known as Access Pharmaceuticals. It was based in Dallas and was incorporated in 1989. In late 2014 the company changed its name to PlasmaTech Biopharmaceuticals. In 2015 PlasmaTech acquired a company based in Cleveland called Abeona Therapeutics which was founded in 2013. In June 2015 the parent company adopted the name Abeona Therapeutics.

The name Abeona comes from a Roman goddess who was said to protect children. The company's stock is traded on NASDAQ under the symbol ABEO.

News

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-03-17 Future report Set alerts
Q3 2020 2020-11-12 Future report Set alerts
Q2 2020 2020-08-10 -0.14 -0.14
Q1 2020 2020-05-06 -0.52 -0.52
Q4 2019 2020-03-16 -0.30 -0.30
Q3 2019 2019-11-12 -0.35 -0.35
Q2 2019 2019-08-09 -0.49 -0.49
Q1 2019 2019-05-10 -0.39 -0.39
Q4 2018 2019-03-18 -0.42 -0.36
Q3 2018 2018-11-09 -0.34 -0.34

Ratings

2016-06-22 Reiterated Rating FBR & Co. Buy
2016-06-22 Reiterated Rating FBR & Co Buy
2016-05-24 Reiterated Rating Maxim Group Buy
2016-05-22 Reiterated Rating FBR & Co. Buy $15.00
2016-05-18 Reiterated Rating Rodman & Renshaw Buy $17.00
2016-05-17 Reiterated Rating Maxim Group Buy $6.00
2016-04-20 Reiterated Rating Rodman & Renshaw Buy $17.00
2016-03-07 Reiterated Rating Maxim Group Buy $6.00
2016-03-01 Reiterated Rating Maxim Group Buy $6.00
2016-02-25 Reiterated Rating FBR & Co. Outperform
2016-01-11 Reiterated Rating Maxim Group Buy $6.00
2015-12-15 Initiated Coverage Maxim Group Buy $6.00
2015-10-30 Reiterated Rating FBR & Co. Outperform
2015-07-20 Initiated Coverage MLV & Co. Buy $15.00
2015-06-11 Initiated Coverage Roth Capital Buy $16.00
2015-05-18 Initiated Coverage HC Wainwright Buy $15.00
2016-06-22 Reiterated Rating FBR & Co. Buy
2016-06-22 Reiterated Rating FBR & Co Buy
2016-05-24 Reiterated Rating Maxim Group Buy
2016-05-22 Reiterated Rating FBR & Co. Buy $15.00
2016-05-18 Reiterated Rating Rodman & Renshaw Buy $17.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In ABEO 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments